VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
PEG+lactulose
Preclinical
Small molecule
R
Renmin Hospital of Wuhan University
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Risk Stratification
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Risk Stratification
Preclinical
Completed
Clinical
Trials by Indication
[1]
Risk Stratification
1 trial
Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification
Completed
·
R
Renmin Hospital of Wuhan University
·
N/A
·
NCT04582942
·
2,028 enrolled
Bowel Preparation
1 trial
Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation
Unknown status
·
R
Renmin Hospital of Wuhan University
·
N/A
·
NCT05498714
·
150 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for PEG+lactulose. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
PEG+lactulose compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for PEG+lactulose. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Renmin Hospital of Wuhan University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
R
Renmin Hospital of Wuhan University
Related News